[Effect of fibroscopic sclerotherapy of hemorrhaging esophageal varices on survival in alcoholic liver cirrhosis (comparative retrospective study)].
Between 1983 and 1992 altogether 638 alcoholic cirrhotic patients had been treated because of acute esophageal variceal bleeding. In 96 cases the treatment were carried out in the following circumstances; volume and coagulation factor substituate, vasopressin or glypressin and nitroglycerin, urgent endoscopy and ballontamponade but in 47 cases an urgent sclerotherapy were also performed. The survival, cases of rebleeding,-from the first bleeding events-of the 49 nonsclerosed patients were compared to those of the 47 sclerosed one.


CONCLUSIONS
1. The endoscopic sclerotherapy proved to be life-saving procedure. 2. Within 30 days the nonsclerosed patients died twice as much number than the slcerosed patients. 3. The lengths of the survival period were found four and half times so long at the sclerosed patients than in nonsclerosed patients (535 versus 125 days). 4. The numbers of the rebleeding were not less at the sclerosed patients than the nonsclerosed subjects. 5. The lengths of the nonbleeding period was found triple so long at the sclerosed patients than in nonsclerosed patients. 6. The survival of the "Child C" patients at the sclerosed and nonsclerosed patients, too. The authors come to conclusion that by the fiberendoscopic sclerotherapy an increase in the survival time of the patients with acute esophageal variceal bleeding in alcoholic cirrhosis can be achieved.
Kempelen
I
I
I. Belgyógyászat, Gasztroenterológiai Osztály Fövarosi Onkormányzat Bajcsy-Zsilinszky Kórház, Budapest.
Káldi
G
G
Nemesánszky
E
E
Rehák
T
T
Nagy
Z
Z
Tagányi
K
K
D000208:Acute Disease; D004932:Esophageal and Gastric Varices / Q000209:etiology* / Q000628:therapy; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology* / Q000628:therapy; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008104:Liver Cirrhosis, Alcoholic / Q000145:classification* / Q000150:complications / Q000401:mortality / Q000628:therapy; D008297:Male; D012189:Retrospective Studies; D015911:Sclerotherapy; D015996:Survival Rate